Targeted alpha particle therapy using actinium-225 conjugates

Details for Australian Patent Application No. 2002211232 (hide)

Owner Sloan Kettering Institute for Cancer Research

Inventors Ma, Dangshe; Mcdevitt, Michael; Borchardt, Paul; Scheinberg, David

Agent Callinan

Pub. Number AU-B-2002211232

PCT Pub. Number WO02/22000

Priority 60232909 15.09.00 US

Filing date 14 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 19 October 2006

International Classifications

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

19 October 2006 Application Accepted

  Published as AU-B-2002211232

15 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211233

2002211231